A computational method was developed to create synthetic receptors called T-SenSERs that are engineered to detect soluble signals found in tumors and convert them into co-stimulatory or cytokine-like signals that boost anticancer T cell activity. The post Computationally Designed Receptors Help Engineered T Cells Control Tumors appeared first on GEN - Genetic Engineering and Biotechnology News.| GEN – Genetic Engineering and Biotechnology News
Electra Therapeutics has completed an oversubscribed $183 million Series C financing it said will fund a global pivotal trial of its lead pipeline candidate, a frontline treatment for secondary hemophagocytic lymphohistiocytosis (sHLH).| GEN - Genetic Engineering and Biotechnology News
Researchers in China have determined to identify the genetic basis for the naked mole-rats’ increased longevity.| GEN - Genetic Engineering and Biotechnology News
Results reported in a preprint connect localized signals in the brain to aging-related changes in immune cells in mouse models.| GEN - Genetic Engineering and Biotechnology News
Two papers reveal insights into how decision-making unfolds across the entire brain in mice at single-cell resolution.| GEN - Genetic Engineering and Biotechnology News
Antibodies from a person who had previously been infected with mpox provides full protection from severe illness and death in mice.| GEN - Genetic Engineering and Biotechnology News
Researchers suggest targeting inflammation may offer a promising therapeutic strategy at the intersection of cancer and cardiovascular disease.| GEN - Genetic Engineering and Biotechnology News
